Dr Antony Rix

Lucida Medical Ltd

Position: Head of Department
Personal home page: https://lucidamedical.com
Email:   enquiries@lucidamedical.com

PubMed journal articles - click here

Research description: 

Co-founded by Prof Evis Sala and Dr Antony Rix, Lucida Medical is a spin-out from the University of Cambridge Department of Radiology and Cambridge University Hospitals. The company develops AI-based software to help automate the analysis of oncological imaging, to make cancer screening, diagnosis and treatment faster, more accurate and effective.

Lucida Medical has recently announced a substantial investment led by XTX Ventures and Prostate Cancer Research - for more details see https://lucidamedical.com/2021-cambridge-ai-startup-prostate-cancer-inve...

Research Programme or Virtual Institute: 
Early Cancer Institute
Secondary Programme: 
Advanced Cancer Imaging
Methods and technologies: 
Clinical practice
Clinical trials
Genomics
Imaging
Immunohistochemistry
Magnetic Resonance Imaging (MRI)
Tumour type interests: 
Prostate
Keywords: 
Prostate cancer diagnosis
artificial intelligence (AI)
machine learning (ML)
magnetic resonance imaging (MRI)

Key publications: 

J Suchanek, AW Rix, AH Mehan, CJL Doran, AR Padhani, C Kastner, T Barrett, E Sala, Multi-stage AI analysis system to support prostate cancer diagnostic imaging. EuSoMII Virtual Annual Meeting, 24 October 2020. Paper available at https://lucidamedical.com/wp-content/uploads/2020/12/Suchanek-J-et-al.-M...

Example outputs of prostate cancer AI prototype, patients with biopsy-verified Gleason Grade Group 2+ prostate cancer.